JOHN BRENNAN

BLUEBIRD STRATEGIES · Washington, DC · registered since 2024

Registered · LDAActive

Send proposal →Contact →Claim this profile →

At a glance

Registered since

2024

Senate LDA system

Clients

last 3 years

Filings

5 agencies contacted

Activity

filings by quarter

Works on

Health Issues 12 Budget/Appropriations 11 Medical/Disease Research/Clinical Labs 11 Medicare/Medicaid 4 Veterans 3

Background

Government experience

Rep. Rosa DeLauro

Chief of Staff

Disclosed on LD-2 filings

Career

BLUEBIRD STRATEGIES

Washington, DC

2024 - present

Specific issues

FY2025 NCATS research funding

Budget/Appropriations · 2024 Q1

Peggy Lillis C. difficile Inclusion Act (H.R. 9098) CDC Infection Disease Public Health & Epidemiology Funding. Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization. Pioneering Antimicrobial Subscriptions to End Upsurging Resistance PASTEUR Act.

Health Issues · 2024 Q3

Legislation to regulate clinical testing/labs.

Medical/Disease Research/Clinical Labs · 2024 Q3

Medicaid coverage for mental health genetic testing. VA access for mental health genetic testing.

Veterans · 2024 Q3

Medicaid precision medicine legislation.

Health Issues · 2024 Q3

Pioneering Antimicrobial Subscriptions to End Upsurging Resistance PASTEUR Act and issues related to sepsis treatment and antibiotic stewardship. CMS SEP-1 measure implementation. CDC AMR activities. Issues related to health insurance coverage and regulation of FDA cleared biomarkers to predict preeclampsia.

Health Issues · 2024 Q3